Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 31 of 31 entries
View as:

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04035226 Org: User:
Start: 08/02/19 End: 10/27/22 Due: 10/27/23

Study to Describe the Actual Situation of Hepatitis C Treatment in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT02773394 Org: User:
Start: 04/12/16 End: 11/30/16 Due: 11/30/17

An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02597270 Org: User:
Start: 03/31/16 End: 11/30/16 Due: 11/30/17

An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders

Phase: N/A Priority: Normal
NCT ID: NCT01855074 Org: User:
Start: 11/30/07 End: 02/28/09 Due: 02/28/10

An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT00771199 Org: User:
Start: 10/31/08 End: 11/30/08 Due: 11/30/09

Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03495973 Org: User:
Start: 10/25/17 End: 11/22/20 Due: 11/22/21